Mike Havrilla on RMTI – Rockwell Medical Technologies Inc …
July 26th, 2009
| Tags: Arthritis, gout, inform-them, internal, internal-server, request, server, the-server, time
On 5/28/09, Poniard Pharma (NASDAQ:PARD) announced updated clinical data from its randomized , controlled Phase 2 trial of picoplatin in patients with metastatic colorectal cancer (CRC). The new data demonstrated that picoplatin, …. SVNT is seeking FDA approval for the infused drug (Krystexxa) for those who have the painful type of arthritis , but fail to improve with first-line treatments or cannot tolerate other treatments.
Read the original here:
Mike Havrilla on RMTI – Rockwell Medical Technologies Inc …
Leave a comment
| Trackback